Alzheimer’s disease affects millions of people worldwide. But despite decades of research costing hundreds of millions of dollars, we have no cure. Why? | The Guardian
Despite drug companies spending decades and hundreds of millions of dollars on development into drugs, so far nothing has been discovered that can stop the disease. But why is Alzheimer’s so hard to cure?
To probe this question Ian Sample is joined by Dr David Reynolds, chief scientific officer at Alzheimer’s Research UK, Professor Roger Morris, a molecular neurobiologist at King’s College London and Professor Giovanna Mallucci from the University of Cambridge.
View the full article and podcast here